SCR 120: Biotechnology Day.
- Session Year: 2015-2016
- House: Senate
- Latest Version Date: 2016-04-11
This measure would declare April 7, 2016, and every April 7 thereafter, as Biotechnology Day in California.
This measure would declare April 7, 2016, and every April 7 thereafter, as Biotechnology Day in California.
This measure would declare April 7, 2016, and every April 7 thereafter, as Biotechnology Day in California.
WHEREAS, California is the global leader in the life sciences industry; and
WHEREAS, This great state is home to the entire continuum of the life sciences industry, including world class universities, basic research centers, biotechnology startups, and anchor biopharmaceutical companies; and
WHEREAS, There are currently 2,848 life sciences companies in California, with 212 more companies than in 2014, generating $130 billion in revenue; and
WHEREAS, California life sciences companies directly employ 281,000 people all over the State of California, with concentrations in the San Francisco Bay area, San Diego, Orange County, and Los Angeles; and
WHEREAS, The life sciences are an economic driver in California, a place where cutting-edge businesses thrive; and
WHEREAS, California has a concentration of research in the life sciences industry; and
WHEREAS, California companies have 1,235 potential new medicines in the pipeline and life science innovations have a tremendous impact on the worlds health and well-being; and
WHEREAS, New medicines and technologies emerging from California companies and research institutions are likely to have a remarkable impact on the health of the worlds population and help those afflicted with serious diseases, such as cancer, cystic fibrosis, heart disease, multiple sclerosis, and rheumatoid arthritis; and
WHEREAS, In the early 1970s, Herb Boyer at the University of California and geneticist Stanley Cohen at Stanford University pioneered a new scientific field called recombinant DNA technology; and
WHEREAS, Venture capitalist, Bob Swanson, who was excited by recombinant DNA technologys potential to help people, and Herb Boyer together founded the first biotechnology company, Genentech, in South San Francisco; and
WHEREAS, The founding of Genentech on April 7, 1976, marked the birth of the biotechnology industry and planted the industrys roots in California; and
WHEREAS, Genentech, a member of the Roche Group, remains a leader in the biotechnology industry and continues to advance its mission of transforming the lives of people with serious diseases; and
WHEREAS, The biotechnology industry inspires the next generation of scientists to help solve challenges like disease, energy, and food security; and
WHEREAS, The biotechnology industry generates nearly $259 billion in economic activity in California, provides more than one million jobs, and is the source of billions of dollars in state and local tax revenue; and
WHEREAS, The largest and most influential biotechnology convention in the world, the BIO International Convention, will take place in San Francisco, California, from June 6th to June 9th, 2016, with more than 15,000 anticipated attendees; and
WHEREAS, San Francisco hosted this convention in 1995 and San Diego will host it in 2017, while the State of California has hosted this convention five other times; and
WHEREAS, The BIO International Convention is where the global biotech community meets, connecting the people, companies, and innovations that help to fulfill the promise of biotechnology through healing, fueling, and feeding the world; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature hereby recognizes April 7, 2016, and every April 7th thereafter, as Biotechnology Day in California; and be it further
Resolved, That the Senate urges Californians to recognize the value and importance of the life sciences industry; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, California is the global leader in the life sciences industry; and
WHEREAS, This great state is home to the entire continuum of the life sciences industry, including world class universities, basic research centers, biotechnology startups, and anchor biopharmaceutical companies; and
WHEREAS, There are currently 2,848 life sciences companies in California, with 212 more companies than in 2014, generating $130 billion in revenue; and
WHEREAS, California life sciences companies directly employ 281,000 people all over the State of California, with concentrations in the San Francisco Bay area, San Diego, Orange County, and Los Angeles; and
WHEREAS, The life sciences are an economic driver in California, a place where cutting-edge businesses thrive; and
WHEREAS, California has a concentration of research in the life sciences industry; and
WHEREAS, California companies have 1,235 potential new medicines in the pipeline and life science innovations have a tremendous impact on the worlds health and well-being; and
WHEREAS, New medicines and technologies emerging from California companies and research institutions are likely to have a remarkable impact on the health of the worlds population and help those afflicted with serious diseases, such as cancer, cystic fibrosis, heart disease, multiple sclerosis, and rheumatoid arthritis; and
WHEREAS, In the early 1970s, Herb Boyer at the University of California and geneticist Stanley Cohen at Stanford University pioneered a new scientific field called recombinant DNA technology; and
WHEREAS, Venture capitalist, Bob Swanson, who was excited by recombinant DNA technologys potential to help people, and Herb Boyer together founded the first biotechnology company, Genentech, in South San Francisco; and
WHEREAS, The founding of Genentech on April 7, 1976, marked the birth of the biotechnology industry and planted the industrys roots in California; and
WHEREAS, Genentech, a member of the Roche Group, remains a leader in the biotechnology industry and continues to advance its mission of transforming the lives of people with serious diseases; and
WHEREAS, The biotechnology industry inspires the next generation of scientists to help solve challenges like disease, energy, and food security; and
WHEREAS, The biotechnology industry generates nearly $259 billion in economic activity in California, provides more than one million jobs, and is the source of billions of dollars in state and local tax revenue; and
WHEREAS, The largest and most influential biotechnology convention in the world, the BIO International Convention, will take place in San Francisco, California, from June 6th to June 9th, 2016, with more than 15,000 anticipated attendees; and
WHEREAS, San Francisco hosted this convention in 1995 and San Diego will host it in 2017, while the State of California has hosted this convention five other times; and
WHEREAS, The BIO International Convention is where the global biotech community meets, connecting the people, companies, and innovations that help to fulfill the promise of biotechnology through healing, fueling, and feeding the world; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature hereby recognizes April 7, 2016, and every April 7th thereafter, as Biotechnology Day in California; and be it further
Resolved, That the Senate urges Californians to recognize the value and importance of the life sciences industry; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
WHEREAS, California is the global leader in the life sciences industry; and
WHEREAS, This great state is home to the entire continuum of the life sciences industry, including world class universities, basic research centers, biotechnology start-ups, and anchor biopharmaceutical companies; and
WHEREAS, There are currently 2,848 life sciences companies in California, with 212 more companies than in 2014, generating $130 billion in revenue; and
WHEREAS, California life sciences companies directly employ 281,000 people all over the State of California, with concentrations in the San Francisco Bay area, San Diego, Orange County, and Los Angeles; and
WHEREAS, The life sciences are an economic driver in California, a place where cutting-edge businesses thrive; and
WHEREAS, California has a concentration of research in the life sciences industry; and
WHEREAS, California companies have 1,235 potential new medicines in the pipeline and life science innovations have a tremendous impact on the worlds health and well-being; and
WHEREAS, New medicines and technologies emerging from California companies and research institutions are likely to have a remarkable impact on the health of the worlds population and help those afflicted with serious diseases, such as cancer, cystic fibrosis, heart disease, multiple sclerosis, and rheumatoid arthritis; and
WHEREAS, In the early 1970s, Herb Boyer at the University of California and geneticist Stanley Cohen at Stanford University pioneered a new scientific field called recombinant DNA technology; and
WHEREAS, Venture capitalist, Bob Swanson, who was excited by recombinant DNA technologys potential to help people, and Herb Boyer together founded the first biotechnology company, Genentech, in South San Francisco; and
WHEREAS, The founding of Genentech on April 7, 1976, marked the birth of the biotechnology industry and planted the industrys roots in California; and
WHEREAS, Genentech, a member of the Roche Group, remains a leader in the biotechnology industry and continues to advance its mission of transforming the lives of people with serious diseases; and
WHEREAS, The biotechnology industry inspires the next generation of scientists to help solve challenges like disease, energy, and food security; and
WHEREAS, The biotechnology industry generates nearly $259 billion in economic activity in California, provides more than one million jobs, and is the source of billions of dollars in state and local tax revenue; and
WHEREAS, The largest and most influential biotechnology convention in the world, the BIO International Convention, will take place in San Francisco, California, from June 6th to June 9th, 2016, with more than 15,000 anticipated attendees; and
WHEREAS, San Francisco hosted this convention in 1995 and San Diego will host it in 2017, while the State of California has hosted this convention five other times; and
WHEREAS, The BIO International Convention is where the global biotech community meets, connecting the people, companies, and innovations that help to fulfill the promise of biotechnology through healing, fueling, and feeding the world; now, therefore, be it
Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature hereby recognizes April 7, 2016, and every April 7th thereafter, as Biotechnology Day in California; and be it further
Resolved, That the Senate urges Californians to recognize the value and importance of the life sciences industry; and be it further
Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
|
Date
|
Status
|
|---|---|
| Mar 16, 2016 | Introduced. Referred to Com. on RLS. |
| Mar 30, 2016 | From committee: Ordered to third reading. |
| Mar 31, 2016 | In Assembly. Held at Desk. |
| Mar 31, 2016 | Read. Adopted. (Ayes 35. Noes 0.) Ordered to the Assembly. |
| Mar 31, 2016 | Read. Adopted. (Ayes 36. Noes 0. Page 3349.) Ordered to the Assembly. |
| Apr 4, 2016 | Referred to Com. on RLS. |
| Apr 7, 2016 | Assembly Rule 63 suspended. |
| Apr 7, 2016 | From committee: Be adopted. Ordered to third reading. (Ayes 9. Noes 0.) (April 7). |
| Apr 7, 2016 | In Senate. Ordered to engrossing and enrolling. |
| Apr 7, 2016 | Read. Adopted. Ordered to the Senate. |
| Apr 7, 2016 | Read. Adopted. (Ayes 77. Noes 0. Page 4225.) Ordered to the Senate. |
| Apr 11, 2016 | Chaptered by Secretary of State. Res. Chapter 21, Statutes of 2016. |
| Apr 11, 2016 | Enrolled and filed with the Secretary of State at 3:30 p.m. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Apr 7, 2016 | SCR 120 Hill Senate Third Reading By MULLIN | Assembly Floor |
Passed |
|
| Apr 7, 2016 | Be adopted. To third reading. | Assembly Standing Committee on Rules |
Passed |
|
| Mar 31, 2016 | Senate 3rd Reading SCR120 Hill | Senate Floor |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| California Life Sciences Association | ** Support | Mar 31, 2016 |
(Without Reference to File)
SENATE THIRD READING
STR Bill Id:SCR 120
Author:(Hill)
As Introduced Ver:March 16, 2016
Majority vote
SENATE VOTE: 36-0
Committee | Votes | Ayes | Noes |
Rules | 9-0 | Gordon, Chang, Cooley, Gomez, Holden, Jones, Mullin, Quirk, Rodriguez |
SUMMARY: Declares April 7, 2016, and every April 7 thereafter, as Biotechnology Day in California. Specifically, this resolution makes the following legislative findings:
- California is the global leader in the life sciences industry and is home to the entire continuum of the life sciences industry, including world class universities, basic research centers, biotechnology start-ups, and anchor biopharmaceutical companies.
- Currently there are 2,848 life sciences companies in California, with 212 more companies than in 2014, generating $130 billion in revenue.
- All over the State of California, life sciences companies employ 281,000 people, with concentrations in the San Francisco Bay area, San Diego, Orange County, and Los Angeles.
- California companies have 1,235 potential new medicines in the pipeline and life science innovations have a tremendous impact on the world's health and well-being. New medicines and technologies emerging from California companies and research institutions are likely to have a remarkable impact on the health of the world's population and help those afflicted with serious diseases, such as cancer, cystic fibrosis, heart disease, multiple sclerosis, and rheumatoid arthritis.
- In the early 1970's, Herb Boyer at the University of California and geneticist Stanley Cohen at Stanford University pioneered a new scientific field called recombinant DNA technology and together with Bob Swanson, a venture capitalist, founded the first biotechnology company, Genentech, in South San Francisco.
- Genentech, a member of the Roche Group, remains the leader in the biotechnology industry and continues to advance its mission of transforming the lives of people with serious diseases.
- The biotechnology industry generates nearly $259 billion in economic activity in California, provides more than one million jobs, and is the source of billions of dollars in state and local tax revenue.
FISCAL EFFECT: None
Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800 FN: 0002712
Date of Hearing: April 7, 2016
ASSEMBLY COMMITTEE ON RULES
Gordon, Chair
SBPCA Bill Id:SCR 120
Author:(Hill) – As Introduced Ver:
SENATE VOTE:
SUBJECT: Biotechnology Day
SUMMARY: Declares April 7, 2016, and every April 7 thereafter, as Biotechnology Day in California. Specifically, this resolution makes the following legislative findings:
- California is the global leader in the life sciences industry and is home to the entire continuum of the life sciences industry, including world class universities, basic research centers, biotechnology start-ups, and anchor biopharmaceutical companies.
- Currently there are 2,848 life sciences companies in California, with 212 more companies than in 2014, generating $130 billion in revenue.
- All over the State of California, life sciences companies employ 281,000 people, with concentrations in the San Francisco Bay area, San Diego, Orange County, and Los Angeles.
- California companies have 1,235 potential new medicines in the pipeline and life science innovations have a tremendous impact on the world's health and well-being. New medicines and technologies emerging from California companies and research institutions are likely to have a remarkable impact on the health of the world's population and help those afflicted with serious diseases, such as cancer, cystic fibrosis, heart disease, multiple sclerosis, and rheumatoid arthritis.
- In the early 1970's, Herb Boyer at the University of California and geneticist Stanley Cohen at Stanford University pioneered a new scientific field called recombinant DNA technology and together with Bob Swanson, a venture capitalist, founded the first biotechnology company, Genentech, in South San Francisco.
- Genentech, a member of the Roche Group, remains the leader in the biotechnology industry and continues to advance its mission of transforming the lives of people with serious diseases.
- The biotechnology industry generates nearly $259 billion in economic activity in California, provides more than one million jobs, and is the source of billions of dollars in state and local tax revenue.
FISCAL EFFECT: None
REGISTERED SUPPORT / OPPOSITION:
Support
None on file
Opposition
None on file
Analysis Prepared by: Nicole Willis / RLS. / (916) 319-2800
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | SCR 120 |
THIRD READING
Bill No: SCR 120
Introduced: 3/16/16
DIGEST:
This resolution declares April 7, 2016, and every April 7 thereafter, as Biotechnology Day in California.
ANALYSIS: This resolution makes the following legislative findings:
- California is the global leader and has a concentration of research in the life sciences industry.
- The life sciences are an economic driver in California, a place where cutting-edge businesses thrive.
- New medicines and technologies emerging from California companies and research institutions are likely to have a remarkable impact on the health of the world’s population and help those afflicted with serious diseases, such as cancer, cystic fibrosis, heart disease, multiple sclerosis, and rheumatoid arthritis.
- The biotechnology industry inspires the next generation of scientists to help solve challenges like disease, energy, and food security.
- The BIO International Convention is the largest and most influential biotechnology convention in the world. It is where the global biotech community meets, connecting the people, companies, and innovations that help to fulfill the promise of biotechnology through healing, fueling, and feeding the world. The Convention will take place in San Francisco, California, from June 6th to June 9th, 2016.
This resolution recognizes April 7, 2016, and every April 7 thereafter, as Biotechnology Day in California, and urges Californians to recognize the value and importance of the life sciences industry.
FISCAL EFFECT: Appropriation: No Fiscal Com.: No Local: No
California Life Sciences Association
OPPOSITION: (Verified 3/28/16)
None received
Prepared by: Karen Chow / SFA / (916) 651-1520
3/30/16 15:39:21
**** END ****
Discussed in Hearing
View Older HearingsBill Author
Bill Co-Author(s):